SCHEMBL8395191

SCHEMBL8395191

CCOC(=O)c1cnc(Cc2ccc(Cl)c(Cl)c2)nc1NN

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FOS P01100 3/20 0.48
▸ JUN P05412 3/20 0.48
▸ NFKB1 P19838 3/20 0.48
▸ NFKB2 Q00653 3/20 0.48
▸ RELA Q04206 3/20 0.48
▸ MAPT P10636 5/20 0.45
▸ ALDH1A1 P00352 5/20 0.45
▸ HSD17B10 Q99714 3/20 0.45
▸ KDM4E B2RXH2 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ NPSR1 Q6W5P4 5/20 0.44
▸ SMN1; SMN2 Q16637 4/20 0.44
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ TSHR P16473 3/20 0.44
▸ CYP4F2 P78329 1/20 0.44
▸ CYP4A11 Q02928 1/20 0.44
▸ XBP1 P17861 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8399290 0.85 ALDH1A1 (0.49) FOSJUNNFKB1NFKB2RELA
SCHEMBL8396925 0.84 CYP4F2 (0.47) FOSJUNNFKB1NFKB2RELA
SCHEMBL8394439 0.83 NFKB1 (0.65) FOSJUNNFKB1NFKB2RELA
SCHEMBL8400061 0.81 CYP1A2 (0.55) FOSJUNNFKB1NFKB2RELA
SCHEMBL10006709 0.77 MAPT (0.53) FOSJUNNFKB1NFKB2RELA
SCHEMBL16816857 0.70 PDE5A (0.61) MAPTALDH1A1HSD17B10NPSR1SMN1; SMN2
SCHEMBL20891573 0.70 KDM4E (0.48) MAPTALDH1A1HSD17B10KDM4ENPC1
SCHEMBL1816274 0.69 SYK (0.69) FOSJUNNFKB1NFKB2RELA
SCHEMBL28409223 0.69 PDE5A (0.60) —
SCHEMBL8398530 0.69 ALDH1A1 (0.71) FOSJUNNFKB1NFKB2RELA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5935966-A COMPOUNDS THAT BLOCK THE ACTIVATION OF TRANSCRIPTION FACTORS THROUGH INHIBITION OF A FAMILY OF SPECIFIC KINASES, DECREASING PROINFLAMMATORY PROTEINS TO TREAT AUTOIMMUNE DISEASES AND AS GENERAL ANTIINFLAMMATORY AGENTS SIGNAL PHARMACEUTICALS, INC. (US) 1999-08-10 — — US disclosed
WO-1998038171-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1998-09-03 — — WO disclosed
WO-1997009325-A1 PYRIMIDINE CARBOXYLATES AND RELATED COMPOUNDS AND METHODS FOR TREATING INFLAMMATORY CONDITIONS SIGNAL PHARMACEUTICALS, INC. (US) 1997-03-13 — — WO disclosed
Send feedback